Abstract
The outer layer of the epidermis or stratum corneum is the major barrier to percutaneous absorption. It has been shown that there are numerous enzyme systems beneath the stratum corneum in the viable epidermis capable of metabolizing drugs. A number of prodrug and soft drug topical therapeutic agents have been designed. After these agents penetrate the stratum corneum, they are metabolized by the cutaneous esterase systems to the desired metabolites.
Similar content being viewed by others
References
Voorhees, J. J., Duell, E. A., Stawiski, M. (1974) Adv. Cyclic Nucl. Res. 4, 117–162.
Aoyagi, T., Umeda, K., Iizuka, H., Miura, Y. (1981) Br. J. Dermatol. 105, 257–266.
Royer, E., Chaintreul, J., Meynadier, J., Michel, B., Guilhou, J. J., Crastes de Paulet, A. (1982) Dermatologica 165, 533–543.
Hammerstrom, S., Hamberg, M., Samuelsson, B., Duell, E., Stawiski, M., Voorhess, J. (1975) Proc. Nat. Acad. Sci. USA 72, 5130–5134.
Hammerstrom, S., Lindgras, J., Marcelo, C., Duell, E., Anderson, T., Voorhess, J. (1979) J. Invest. Dermatol. 72, 268.
Penneys, N. S., Eaglstein, W., Ziboh, V. (1980) Br. J. Dermatol. 103, 257–262.
Russel, D. H., Stawiski, M. A., Duell, E. A. (1976) Pharmacologist 18, 157.
Voorhees, J. J. (1979) Archs. Derm. 115, 943–944.
Rheinwald, J. G., Green, H. (1977) Nature 265, 421–424.
Frati, L., D'Armiento, M., Gulletta, E., Verna, R., Covelli, I. (1977) Pharm. Res. Commun. 9, 815–822.
Carpenter, G. (1979) Ann. Rev. Biochem. 48, 193–216.
Schalla, W., Schaefer, H. (1982) in: Dermal and Transdermal Absorption (Brandau, R., and B. H. Lippoid, eds.) pp. 41–72, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany.
Wester, R. C., Maibach, H. I. (1983) Drug Met. Rev. 14, 169–205.
Tauber, U. (1981) in: Dermal and Transdermal Absorption (Brandau, R., and Lippoid, B. H., eds.) pp. 134–151, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany.
Feldmann, R. J., Maibach, H. I., (1967) J. Invest. Dermatol. 48, 181–183.
Bartek, M. J., La Budde (1975) in: Animal Models in Dermatology (Maibach, H. I., ed.) pp. 103–120, Churchill Livingstone, New York.
Leung, L. C., Ando. H. Y. (1979) J. Pharm. Sci. 68, 571–574.
Smith, L. H., Holland, J. M. (1981) Toxicol. 21, 47–57.
Koa, J., Hall, J., Holland, J. M. (1982) Toxicol. Appl. Pharmacol. 68, 206–217.
Holland, J. M., Kao, J. Y., Whitaker, M. J. (1984) Toxicol. Appl. Pharmacol. 72, 272–280.
Bundgaard, H., Hoelgaard, A., Mollgaard, B. (1983) Int. J. Pharm. 15, 285–292.
Morsches, B., Holzmann, H. (1982) Arzneim.-Forsch. 32, 298–300.
Wester, R. C., Noonan, P. K., Smeach, S., Kosobud, L. (1983) J. Pharm. Sci. 72, 745–748.
Rongone, E. L. (1977) in: Advances in Modern Toxicology Vol. 4: Dermatology and Pharmacology (Marzulli, F. N., and Maibach, H. I., eds.) pp. 93–137, Hemisphere Publishing Corp., Washington D.C.
Pannatier, A., Jenner, P., Testa, B., Etter, C. (1978) Drug Met. Rev. 8, 319–343.
Noonan, P. K., Wester, R. C. (1982) in: Dermatotoxicology, second edition (Marzulli, F. N., and Maibach, H. I., eds.) pp. 71–90, Hemisphere Publishing Corp., Washington D.C.
Pohl, R., Philpot, R., Fouts, J. (1976) Drug Metab. Dispos. 4, 442–450.
Bowden, G., Slaga, T., Shapas, B., Boutwill, R. (1974) Cancer Res. 34, 2634–2642.
Cox, J. S. G., Beach, J. E., Blair, A. M. J. N., King, J., Lee, T. B., Loveday, D. E. E., Moss, G. F., Orr, T. S. C., Ritche, J. T., Sheard, P. (1970) in: Advances in Drug Research, Vol. 5 (Harper, N. J., and Simmons, A. B., eds.) pp. 115, John Wiley, New York and London.
Haider, S. A. (1977) Br. Med. J. 1, 1570–1572.
Bodor, N., Zupan, J., Selk, S. (1980) Int. J. Pharm. 7, 63–75.
Weirich, E. G., Lonfauer, J. K., Kirkwood, A. K. (1976) Dermatologica 152, 87–99.
Loftsson, T., Kaminski, J. J., Bodor, N. (1981) J. Pharm. Sci. 70, 743–749.
Loftsson, T., Kaminski, J. J., Bodor, N. (1981) J. Pharm. Sci. 70, 756–758.
Sloan, K. B., Bodor, N. (1982) J. Pharm. Sci. 12, 299–313.
Mollgaard, B., Annie, H., Bundgaard, H. (1982) J. Pharm. Sci. 71, 153–162.
Fondak, A. A., Friedman, A. E., Klein, R. J. (1975) Abstract from a symposium at Stanford University, Stanford, Calif., Aug. 26–29.
Lieberman, M., Schafer, T. W., Putt, S. R. (1973) J. Invest. Dermatol. 60, 203–206.
Yu, C. D., Fox, J. L., Ho, N. F. H., Higuchi, W. I. (1979) J. Pharm. Sci. 68, 1341–1346.
Yu, C. D., Fox, J. L., Ho, N. F. H., Higuchi, W. I. (1979) J. Pharm. Sci. 68, 1347–1357.
Shannon, W. M., Baker, D. C., Higuchi, W. I. (1983) 185th National Meeting of the American Chemical Society, March 20–25, Seattle, Washington.
Sloan, K. B., Hashida, M., Alexander, J., Bodor, N., Higuchi, T. (1983) J. Pharm. Sci. 72, 372–378.
Bodor, N. (1977) in: Design of Biopharmaceutical Properties by Prodrug and Analogs (Roche, E. B., ed.) pp. 98, Academy of Pharmaceutical Sciences, Washington D.C.
Kapp, J. F., Koch, H., Topert, H., Kessler, J., Gerhards, E. (1977) Arzneim.-Forsch. 27, 2191–2204.
Yeung, D., Nacht, S., Bucks, D., Maibach, H. (1982) Clin. Res. 30, 616A.
Maibach, H. I., Robertson, D. B. (1982) in: Basic and Clinical Pharmacology (Katzung, B. G., ed.) pp. 708–722, Lange Medical Publications, Calif.
Bodor, N., Kaminski, J. J., Selk, S. (1980) J. Med. Chem. 23, 469–474.
Bodor, N., Woods, R., Kaminski, J. J. (1980) J. Med. Chem. 23, 474–480.
Bodor, N., Sloan, K. B., Little, R. J., Selk, S. H., Caldwell, L. (1982) Int. J. Pharm. 10, 307–321.
Bodor, N., Sloan, K. B. (1980) U.S. Patent 4, 213, 978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bucks, D.A.W. Skin Structure and Metabolism: Relevance to the Design of Cutaneous Therapeutics. Pharm Res 1, 148–153 (1984). https://doi.org/10.1023/A:1016340423079
Issue Date:
DOI: https://doi.org/10.1023/A:1016340423079